Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine vs Methylated Spirit for Omphalitis Prophylaxis in Newborns
NCT06002295Phase 2Completed
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in omphalitis and neonatal sepsis comparing Chlorhexidine with Methylated Spirit (2 arms). Primary endpoint: Number of participants with Omphalitis at 10 days. Started Sep 2020; status: completed.
02
Drugs
chlorhexidine + cymenol gelmethylated spirit
03
Conditions
omphalitisneonatal sepsis
Beyond the preview
Go deeper on NCT06002295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06002295.